Exane Derivatives’s Polaris PII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$99 Hold
1
﹤0.01% 715
2022
Q1
$105 Hold
1
﹤0.01% 988
2021
Q4
$110 Sell
1
-461
-100% -$54.3K ﹤0.01% 859
2021
Q3
$55.3K Sell
462
-95
-17% -$12.1K 0.01% 610
2021
Q2
$72.8K Sell
557
-2,172
-80% -$294K 0.02% 581
2021
Q1
$364K Buy
2,729
+396
+17% +$48.3K 0.1% 189
2020
Q4
$222K Buy
2,333
+765
+49% +$73.2K 0.07% 298
2020
Q3
$148K Buy
1,568
+878
+127% +$86.5K 0.04% 240
2020
Q2
$63.9K Sell
690
-1,912
-73% -$146K 0.02% 337
2020
Q1
$125K Sell
2,602
-37,475
-94% -$3.07M 0.04% 253
2019
Q4
$3.76M Buy
+40,077
New +$3.89M 0.7% 37
2015
Q1
Sell
-66
Closed -$9.98K 552
2014
Q4
$9.98K Buy
+66
New +$9.9K ﹤0.01% 414

Other funds holding PII

Exane Derivatives's PII Position: Q2 2022 in Review

Exane Derivatives held its Polaris (PII) position steady in Q2 2022 at 1 share worth $99. The position accounts for ﹤0.01% of the portfolio, ranked #715.

Exane Derivatives first reported a position in PII in Q4 2014 and has held it in 12 quarters since. The position peaked at $3.76M in Q4 2019. 436 funds tracked by Wall St. Rank hold PII as of Q2 2022.

  • Exane Derivatives held 1 share of Polaris worth $99 as of Q2 2022.
  • Exane Derivatives left its Polaris share count unchanged in Q2 2022.
  • Polaris made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #715 holding.
  • Exane Derivatives first reported a position in Polaris in Q4 2014 and has held it in 12 quarters since.
  • Exane Derivatives's Polaris position peaked at $3.76M in Q4 2019.
  • 436 funds tracked by Wall St. Rank held Polaris as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.